Prospera Financial Services Inc Zymeworks Inc. Transaction History

Prospera Financial Services Inc

  • $3.82 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$4.82 - $7.7 $52,885 - $84,484
-10,972 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$6.0 - $16.98 $65,832 - $186,304
10,972 New
10,972 $72,000
Q4 2020

Feb 12, 2021
SELL
$39.12 - $54.99 $2,934 - $4,124
-75 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$29.21 - $46.58 $2,190 - $3,493
75 New
75 $3,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $872M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email